"All on news that CEO Elliott Hill bought 16,400 shares for about $1 million. This follows news that Apple's Tim Cook bought $3 million worth of Nike stock. Cook, who has been on the NKE board since 2005, bought 50,000 shares at an average price of $58.97. Robert Swan, another Nike director, bought about $500,000 of stock on Dec. 22 at an average price of $57.54."
"All after Nike suffered with China sales, declining gross margins, and a cautious outlook. Technically, after catching strong support at about $57, the oversold shoe giant is starting to pivot higher. Last trading at $62, it's also starting to pivot from overextensions on RSI, MACD, and Williams' %R. From here, we'd like to see it initially refill its bearish gap at around $66.20 a share over the next few days."
""Up to 76% of people with Alzheimer's disease experience agitation, representing a significant unmet medical need for patients and their caregivers, and currently, there is a dearth of approved treatments. We look forward to continuing to work with the FDA for the remainder of the review," said Herriot Tabuteau, MD, CEO, as quoted in a company press release."
Nike saw insider purchases by CEO Elliott Hill, Tim Cook and director Robert Swan after weakness from China sales, falling gross margins, and a cautious outlook. Nike found support near $57 and has begun a technical pivot higher, trading around $62 with indicators unwinding overextensions; a refill of the bearish gap near $66.20 is a near-term target. Axsome Therapeutics jumped about 18% after the FDA granted priority review for AXS-05 to treat agitation in Alzheimer's disease, with an April 30, 2026 target action date. Nvidia asked TSMC to ramp H200 production amid large 2026 orders from Chinese tech companies.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]